Table 2.
Cardiovascular magnetic resonance data of patients with gynecologic cancer and healthy control subjects.
| Healthy Control Subjects (n = 30) |
Patients with Gynecologic Cancer (n = 68) |
P value | |
|---|---|---|---|
| Left ventricular function parameters | |||
| LVEDVi (mL/m2) | 64.4 ± 7.2 | 60.9 ± 16.1 | 0.259 |
| LVESVi (mL/m2) | 23.6 ± 5.2 | 22.5 ± 13.4 | 0.693 |
| LVSVi (mL/m2) | 40.9 ± 4.0 | 38.3 ± 7.9 | 0.104 |
| LVMi (g/m2) | 43.5 (36.7, 47.8) | 41.5 (35.3, 47.2) | 0.386 |
| LVEF (%) | 63.7 ± 5.0 | 64.2 ± 7.7 | 0.753 |
| Left ventricular strain parameters | |||
| GLS | −17.4 ± 2.0 | −16.2 ± 2.8 | 0.040 * |
| GCS | −24.3 (−25.6, −21.8) | −23.4 (−24.8, −21.3) | 0.068 |
| GRS | 43.3 ± 7.7 | 39.5 ± 8.9 | 0.054 |
| Left ventricular tissue characterization | |||
| LV Native T1 (ms) | 1267 (1243, 1283) | 1273 (1251, 1298) | 0.176 |
| LV ECV (%) a | 24.5 ± 1.7 | 27.2 ± 2.7 | <0.001 * |
| LV ICMi (g/m2) a | 32.79 (27.74, 35.76) | 30.46 (25.50, 36.40) | 0.098 |
Values are the mean ± SD or median (interquartile range). aLeft ventricular tissue characterization data were available for 30 of 30 healthy control subjects and 58 of 68 patients with gynecologic cancer. GCS, global circumferential strain; GLS, global longitudinal strain; GRS, global radial strain; LV ECV, left ventricular extracellular volume fraction; LVEDVi, left ventricular end-diastolic volume indexed; LVEF, left ventricular ejection fraction; LVESVi, left ventricular end-systolic volume indexed; LV ICMi, left ventricular intracellular mass indexed; LVMi, left ventricular mass indexed.
*P < 0.05.